Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05453799
Title Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Northwestern University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST